Form 8-K - Current report:
SEC Accession No. 0001232524-25-000009
Filing Date
2025-02-25
Accepted
2025-02-25 16:06:16
Documents
15
Period of Report
2025-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20250225.htm   iXBRL 8-K 28755
2 EX-99.1 a4q24financialpr.htm EX-99.1 570749
6 GRAPHIC jazzpharma_logoxfullcolor.jpg GRAPHIC 120198
  Complete submission text file 0001232524-25-000009.txt   935807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20250225.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20250225_lab.xml EX-101.LAB 23507
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20250225_pre.xml EX-101.PRE 13530
18 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20250225_htm.xml XML 2906
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 25663035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)